Conventional MRI lacks sensitivity for quantifying myelin damage, but advanced MRI techniques are proving effective. The development of targeted therapeutics requires histological validation of myelin imaging results, alongside the crucial task of establishing correlations between myelin imaging results and clinical assessments, so that the effectiveness of therapeutic interventions can be evaluated. To this end, improvements in imaging for multiple sclerosis and other diseases of the myelin or white matter loss diseases are still needed.
UCSF investigators have developed a novel MRI sequence to image myelin bilayer in the brain. This sequence is more efficient and provides several different contrasts with single acquisition, and the sensitivity of the sequence to abnormalities in the brain was demonstrated in multiple sclerosis patients.
Patent Pending
MRI, myelin imaging, white matter loss, pulse sequence, ultra-short echo time, 3D rosette trajectory, balanced steady-state free precession